Introducing insulin into diabetes management: Transition strategies for older adults

Journal of Gerontological Nursing

Volumn 37, Issue 4, 2011, Pages 10-14

  Spain, Margaret ^a   Edlund, Barbara J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79954620969     PISSN: 00989134     EISSN: None     Source Type: Journal    
DOI: 10.3928/00989134-20110309-01     Document Type: Article

References (22)

1. American Diabetes Association. (2011). Standards of medical care in diabetes-2011. Diabetes Care, 34. Retrieved from http://care.diabetesjournals.org/content/34/Supplement_1/S11.full
2. Ashe, C.V., Shane-McWhorter, L., & Raparla, S. (2010). Health economics and compliance of vials/syringes versus pen devices: A review of the evidence. Diabetes Techonology and Therapeutics, 12(Suppl. 1), S101-S108.
3. Case Western Reserve University. (2010, July 1). Visually impaired people get insulin pen dosages right, study finds [Press re lease]. Retrieved from the Science Daily website: http://www.sciencedaily.com/releases/2010/07/100701103417.htm
4. Centers for Medicare & Medicaid Services. (2010). Medicare and you: 2011 (CMS Product No. 10050). Retrieved from http://www.medicare.gov/publications/pubs/pdf/10050.pdf
5. Chelliah, A., & Burge, M.R. (2004). Hypoglycemia in elderly patients with diabetes mellitus: Causes and strategies for prevention. Drugs and Aging, 21, 511-530.
6. Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975). "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
7. Garg, S.K. (2010). Impact of insulin delivery devices in diabetes care. Diabetes Techonology and Therapeutics, 12(Suppl. 1), S1-S3.
8. Haak, T., Edelman, S., Walter, C., Lecointre, B., & Spollett, G. (2007). Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, Lilly Disposable pen, and a prototype pen: An open-label study. Clinical Therapeutics, 29, 650-660.
9. Hendra, T.J. (2002). Starting insulin therapy in elderly patients. Journal of the Royal Society of Medicine, 95, 453-455.
10. Katz, S. (1983). Assessing self-maintenance: Activities of daily living, mobility, and instrumental activities of daily living. Journal of the American Geriatrics Society, 31, 721-727.
11. Korytkowski, M., Bell, D., Jacobsen, C., & Suwannasari, R. (2003). A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clinical Therapeutics, 25, 2836-2848.
12. Mayfield, J.A., & White, R.D. (2004). Insulin therapy for type 2 diabetes: Rescue, augmentation, and replacement of beta-cell function. American Family Physician, 70, 489-500.
13. Nathan, D.M., Buse, J.B., Davidson, M.B., Ferrannini, E., Holman, R.R., Sherwin, R., & Zinman, B. (2009). Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 32, 193-203.
14. Ober, S.K., Watts, S., & Lawrence, R.H. (2006). Insulin use in elderly diabetic patients. Clinical Interventions in Aging, 1, 107-113.
15. Odegard, P.S., Setter, S.M., & Neumiller, J.J. (2007). Considerations for the pharmacologic treatment of diabetes in older adults. Diabetes Spectrum, 20. Retrieved from http://spectrum.diabetesjournals.org/content/20/4/239.full
16. Polonsky, W.H., & Skinner, T.C. (2010). Perceived treatment efficacy: An overlooked opportunity in diabetes care. Clinical Diabetes, 28. Retrieved from http://clinical.diabetesjournals.org/content/28/2/89.full
17. Sheikh-Ali, M., & Chehade, J.M. (2009). A rational approach to the initiation of insulin therapy in older adults. Geriatrics & Aging, 12, 135-140.
18. Skyler, J.S., Bergenstal, R., Bonow, R.O., Buse, J., Deewani, P., Gale, E.,...Sherwin, R.S. (2009). Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA Diabetes trials. Diabetes Care, 32, 187-192.
19. Spollett, G. (2008). Insulin devices: Addressing barriers to insulin therapy with the ideal pen. The Diabetes Educator, 34, 957-967.
20. Valentine, V., & Kruger, D.F. (2010). Considerations in insulin delivery device selection. Diabetes Techonology and Therapeutics, 12(Suppl. 1), S98-S100.
21. Wang, F., Carabino, J.M., & Vergara, C.M. (2003). Insulin glargine: A systematic review of longacting insulin analogue. Clinical Therapeutics, 25, 1541-1577.
22. Yesavage, J.A., Brink, T.L., Rose, T.L., Lum, O., Huang, V., Adey, M., & Leirer, V.O. (1982-1983). Development and validation of a geriatric depression screening scale: A preliminary report. Journal of Psychiatric Research, 17, 37-49.